Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

[Thromboembolic vein disease (TVD): antithrombotic therapy choice in ASL TO3.]

Cavagna L, Falcone U, Dalmasso M, Migliardi A, Altini A, Bena A, Cavallo MR.

Recenti Prog Med. 2019 Sep;110(9):426-435. doi: 10.1701/3215.31936. Italian.

PMID:
31593179
2.

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, Calderan L, Cagnone M, Pacini C, Cavagna L, Recalde H, Distler JHW, Giustra M, Prosperi D, Colombo M, Meloni F, Montecucco C.

J Control Release. 2019 Sep 28;310:198-208. doi: 10.1016/j.jconrel.2019.08.015. Epub 2019 Aug 17.

PMID:
31430501
3.

Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.

Bruschi M, Bonanni A, Petretto A, Vaglio A, Pratesi F, Santucci L, Migliorini P, Bertelli R, Galetti M, Belletti S, Cavagna L, Moroni G, Franceschini F, Fredi M, Pazzola G, Allegri L, Sinico RA, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Ramoino P, Bianchini P, Puppo F, Pupo F, Negrini S, Mattana F, Emmi G, Garibotto G, Santoro D, Scolari F, Ravelli A, Tincani A, Cravedi P, Volpi S, Candiano G, Ghiggeri GM.

J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232. [Epub ahead of print]

PMID:
31092713
4.

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.

Crisafulli S, Sultana J, Ingrasciotta Y, Addis A, Cananzi P, Cavagna L, Conter V, D'Angelo G, Ferrajolo C, Mantovani L, Pastorello M, Scondotto S, Trifirò G.

Expert Opin Drug Saf. 2019 Jun;18(6):497-509. doi: 10.1080/14740338.2019.1614165. Epub 2019 May 22. Review.

PMID:
31059293
5.

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Bartoloni E, Bistoni O, Alunno A, Cavagna L, Nalotto L, Baldini C, Priori R, Fischetti C, Fredi M, Quartuccio L, Carubbi F, Montecucco C, Doria A, Mosca M, Valesini G, Franceschini F, De Vita S, Giacomelli R, Mirabelli G, Bini V, Gabrielli A, Catassi C, Gerli R.

J Clin Med. 2019 Apr 19;8(4). pii: E540. doi: 10.3390/jcm8040540.

6.

Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al.

Knitza J, Cavagna L, Schett G, Distler JHW.

Ann Rheum Dis. 2019 Apr 17. pii: annrheumdis-2019-215484. doi: 10.1136/annrheumdis-2019-215484. [Epub ahead of print] No abstract available.

PMID:
30995979
7.

[Real World Management of Gouty Arthritis: Clinical, Epidemiological and Comorbidity Data from 4016 Patients in Rhineland-Palatinate, Germany].

Triantafyllias K, Clasen M, Cavagna L, de Blasi M, Klonowski A, Schwarting A.

Dtsch Med Wochenschr. 2019 Apr;144(8):e51-e57. doi: 10.1055/a-0755-1341. Epub 2019 Apr 15. German.

PMID:
30986856
8.

High cardiovascular risk in mixed connective tissue disease: evaluation of macrovascular involvement and its predictors by aortic pulse wave velocity.

Triantafyllias K, de Blasi M, Lütgendorf F, Cavagna L, Stortz M, Weinmann-Menke J, Konstantinides S, Galle PR, Schwarting A.

Clin Exp Rheumatol. 2019 Apr 2. [Epub ahead of print]

PMID:
30943141
9.

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay.

Cassaniti I, Cavagna L, Calarota SA, Adzasehoun KMG, Comolli G, Montecucco C, Baldanti F.

J Immunol Res. 2019 Feb 17;2019:4236503. doi: 10.1155/2019/4236503. eCollection 2019.

10.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

11.

Nailfold videocapillaroscopy in antisynthetase syndrome.

Cassone G, Sebastiani M, Cavagna L, Triantafyllias K, Codullo V, Salvarani C, Manfredi A.

Reumatismo. 2018 Dec 20;70(4):257-258. doi: 10.4081/reumatismo.2018.1105.

12.

"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity.

Canzi P, Aprile F, Manfrin M, Avato I, Magnetto M, Minervini D, Cavagna L, Benazzo M.

J Int Adv Otol. 2019 Apr;15(1):156-159. doi: 10.5152/iao.2018.5463.

13.

One year in review 2018: idiopathic inflammatory myopathies.

Marasco E, Cioffi E, Cometi L, Valentini V, Zanframundo G, Neri R, Cavagna L, Barsotti S.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):937-947. Epub 2018 Dec 6. Review.

14.

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O'Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M; American and European Network of Antisynthetase Syndrome Collaborative Group.

J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15.

PMID:
30442823
15.

Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.

Ruberto G, Bruttini C, Tinelli C, Cavagna L, Bianchi A, Milano G.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2201-2210. doi: 10.1007/s00417-018-4103-9. Epub 2018 Aug 27.

PMID:
30151601
16.

Interstitial pneumonia with autoimmune features: a new classification still on the move.

Cavagna L, Gonzalez Gay MA, Allanore Y, Matucci-Cerinic M.

Eur Respir Rev. 2018 Jun 27;27(148). pii: 180047. doi: 10.1183/16000617.0047-2018. Print 2018 Jun 30. No abstract available.

17.

Consideration of Antisynthetase Syndrome Features in Classifying Patients as Having Idiopathic Inflammatory Myopathy: Comment on the Article by Lundberg et al.

Castañeda S, Cavagna L, González-Gay MA; American and European Network of Antisynthetase Syndrome Collaborative Group.

Arthritis Rheumatol. 2018 Jun;70(6):975-976. doi: 10.1002/art.40478. Epub 2018 Apr 29. No abstract available.

18.

New Criteria Needed for Antisynthetase Syndrome.

Castañeda S, Cavagna L, González-Gay MA.

JAMA Neurol. 2018 Feb 1;75(2):258-259. doi: 10.1001/jamaneurol.2017.3872. No abstract available.

PMID:
29255888
19.

One year in review 2017: idiopathic inflammatory myopathies.

Barsotti S, Bruni C, Cometi L, Valentini V, Cioffi E, Neri R, Cavagna L.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):875-884. Epub 2017 Nov 29. Review.

PMID:
29185960
20.

Brief Report: Validation of a Definition of Flare in Patients With Established Gout.

Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Eliseev M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W.

Arthritis Rheumatol. 2018 Mar;70(3):462-467. doi: 10.1002/art.40381. Epub 2018 Feb 6.

21.

Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria.

Cavagna L, Castañeda S, Sciré C, Gonzalez-Gay MA; AENEAS Collaborative Group Members.

Ann Rheum Dis. 2018 Aug;77(8):e50. doi: 10.1136/annrheumdis-2017-212368. Epub 2017 Sep 25. No abstract available.

PMID:
28970214
22.

Clinical spectrum of anti-Jo-1-associated disease.

Monti S, Montecucco C, Cavagna L.

Curr Opin Rheumatol. 2017 Nov;29(6):612-617. doi: 10.1097/BOR.0000000000000434. Review.

PMID:
28796005
23.

How I treat idiopathic patients with inflammatory myopathies in the clinical practice.

Cavagna L, Monti S, Caporali R, Gatto M, Iaccarino L, Doria A.

Autoimmun Rev. 2017 Oct;16(10):999-1007. doi: 10.1016/j.autrev.2017.07.016. Epub 2017 Aug 2. Review.

PMID:
28778704
24.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

25.

Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.

Capaccio P, Canzi P, Torretta S, Rossi V, Benazzo M, Bossi A, Vitali C, Cavagna L, Pignataro L.

Clin Otolaryngol. 2018 Feb;43(1):96-102. doi: 10.1111/coa.12911. Epub 2017 Jun 26.

PMID:
28585263
26.

Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies.

Scirè CA, Gonzalez-Gay MA, Selva-O'Callaghan A, Cavagna L.

Respir Med. 2017 Nov;132:265-266. doi: 10.1016/j.rmed.2017.03.028. Epub 2017 Mar 31. No abstract available.

PMID:
28385573
27.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
28.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

29.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

30.

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.

Cavagna L, Codullo V, Ghio S, Scirè CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R.

Medicine (Baltimore). 2016 Sep;95(39):e4827. doi: 10.1097/MD.0000000000004827.

31.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
32.

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Ralph Schumacher H, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

J Rheumatol. 2016 Jan;43(1):150-3. doi: 10.3899/jrheum.150684. Epub 2015 Dec 1.

PMID:
26628602
33.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

34.

Genetics and novel aspects of therapies in systemic lupus erythematosus.

Relle M, Weinmann-Menke J, Scorletti E, Cavagna L, Schwarting A.

Autoimmun Rev. 2015 Nov;14(11):1005-18. doi: 10.1016/j.autrev.2015.07.003. Epub 2015 Jul 9. Review.

PMID:
26164648
35.

Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference.

Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.

Autoimmun Rev. 2015 Aug;14(8):692-702. doi: 10.1016/j.autrev.2015.04.004. Epub 2015 Apr 14. Review.

PMID:
25888464
36.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-15. doi: 10.1002/acr.22585.

37.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
38.

Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.

Cavagna L, Saketkoo LA, Schwarting A, Caporali R.

Biomed Res Int. 2014;2014:481973. doi: 10.1155/2014/481973. Epub 2014 Aug 10. No abstract available.

39.

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

Filippini M, Bazzani C, Atzeni F, Sarzi Puttini P, Marchesoni A, Favalli EG, Caporali R, Cavagna L, Gorla R.

Biomed Res Int. 2014;2014:416892. doi: 10.1155/2014/416892. Epub 2014 Jul 6.

40.

Colony-stimulating factor-1: a potential biomarker for lupus nephritis.

Menke J, Amann K, Cavagna L, Blettner M, Weinmann A, Schwarting A, Kelley VR.

J Am Soc Nephrol. 2015 Feb;26(2):379-89. doi: 10.1681/ASN.2013121356. Epub 2014 Jul 10.

41.

A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria.

Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL.

Autoimmun Rev. 2014 Nov;13(11):1142-8. doi: 10.1016/j.autrev.2014.05.009. Epub 2014 May 29. Review.

PMID:
24879966
42.

The emerging role of biotechnological drugs in the treatment of gout.

Cavagna L, Taylor WJ.

Biomed Res Int. 2014;2014:264859. doi: 10.1155/2014/264859. Epub 2014 Apr 16. Review.

43.

The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.

Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, Tari DU, Linguiti C, Perrotta M, Nucita A, Pellegrini F, Fontana A, Cavagna L, Santoro D, Trifirò G.

PLoS One. 2014 Feb 18;9(2):e89072. doi: 10.1371/journal.pone.0089072. eCollection 2014.

44.

[New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].

Cavagna L, Scorletti E, Romano M, Cagnotto G, Caporali R.

G Ital Nefrol. 2013 Jul-Aug;30(4). pii: gin/30.4.9. Italian.

PMID:
24403199
45.

Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Diamanti L, Berzero G, Bini P, Ravaglia S, Rognone E, Cavagna L, Marchioni E.

J Neurol. 2014 Feb;261(2):438-40. doi: 10.1007/s00415-013-7217-3. Epub 2013 Dec 25. No abstract available.

PMID:
24368404
46.

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Cavagna L, Monti S, Grosso V, Boffini N, Scorletti E, Crepaldi G, Caporali R.

Biomed Res Int. 2013;2013:759760. doi: 10.1155/2013/759760. Epub 2013 Sep 25. Review.

47.

Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus.

Cavagna L, Scorletti E, Inverardi F, Baldanti F, Campanini G, Montecucco C, Caporali R.

Lupus. 2013 Sep;22(10):1087-8. doi: 10.1177/0961203313498794. Epub 2013 Jul 24. No abstract available.

PMID:
23884984
48.

WITHDRAWN: Abatacept as a first-line biological therapy.

Caporali R, Bugatti S, Cavagna L, Antivalle M, Atzeni F, Puttini PS.

Autoimmun Rev. 2013 Jun 24. pii: S1568-9972(13)00114-6. doi: 10.1016/j.autrev.2013.06.010. [Epub ahead of print]

PMID:
23806564
49.

Long-term safety of abatacept in patients with rheumatoid arthritis.

Atzeni F, Sarzi-Puttini P, Mutti A, Bugatti S, Cavagna L, Caporali R.

Autoimmun Rev. 2013 Oct;12(12):1115-7. doi: 10.1016/j.autrev.2013.06.011. Epub 2013 Jun 22. Review.

PMID:
23800448
50.

Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment?

Caporali R, Bugatti S, Cavagna L, Antivalle M, Sarzi-Puttini P.

Autoimmun Rev. 2014 Jan;13(1):49-53. doi: 10.1016/j.autrev.2013.06.008. Epub 2013 Jun 15. Review.

PMID:
23777823

Supplemental Content

Loading ...
Support Center